Literature DB >> 28866089

The association between non-alcoholic fatty liver disease and atrial fibrillation: A meta-analysis.

Karn Wijarnpreecha1, Boonphiphop Boonpheng2, Charat Thongprayoon3, Veeravich Jaruvongvanich4, Patompong Ungprasert5.   

Abstract

BACKGROUND/
OBJECTIVES: The association between non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) has been suggested by recent epidemiological studies although the results were inconsistent. This meta-analysis was conducted to summarize all available data.
METHODS: A comprehensive literature review was conducted using MEDLINE and EMBASE database through May 2017 to identify all studies that reported the risk of AF among patients with NAFLD versus those without NAFLD. Effect estimates from each study were extracted and combined together using the random-effect, generic inverse variance method of DerSimonian and Laird.
RESULTS: Of 1009 studies, 5 studies (two cross-sectional studies and three cohort studies) with 238,129 participants met the eligibility criteria and were included in the meta-analysis. The risk of AF in patients with NAFLD was significantly higher than subjects without NAFLD with the pooled risks ratio of 2.06 (95% confidence interval, 1.10-3.85). The statistical heterogeneity was high with an I2 of 78%, which was the major limitation of this meta-analysis.
CONCLUSIONS: A significantly increased risk of AF among patients with NAFLD was demonstrated in this study.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Atrial arrhythmia; Atrial fibrillation; Meta-analysis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis

Mesh:

Year:  2017        PMID: 28866089     DOI: 10.1016/j.clinre.2017.08.001

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  13 in total

1.  Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Karn Wijarnpreecha; Panadeekarn Panjawatanan; Paul T Kroner; Wisit Cheungpasitporn; Patompong Ungprasert
Journal:  Ann Gastroenterol       Date:  2020-09-16

2.  Nonalcoholic Fatty Liver Disease Is Associated with Increased Atrial Fibrillation Risk in an Elderly Chinese Population: A Cross-Sectional Study.

Authors:  Yu Zhang; Peifei Li; Min Miao; Yi Liu; Yue Pan; Lu Xu; Zhongwei Zhu; Chengfu Xu; Lei Xu
Journal:  Biomed Res Int       Date:  2018-07-19       Impact factor: 3.411

Review 3.  Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.

Authors:  Hamza El Hadi; Angelo Di Vincenzo; Roberto Vettor; Marco Rossato
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

Review 4.  Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications.

Authors:  Claudio Tana; Stefano Ballestri; Fabrizio Ricci; Angelo Di Vincenzo; Andrea Ticinesi; Sabina Gallina; Maria Adele Giamberardino; Francesco Cipollone; Richard Sutton; Roberto Vettor; Artur Fedorowski; Tiziana Meschi
Journal:  Int J Environ Res Public Health       Date:  2019-08-26       Impact factor: 3.390

Review 5.  Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues.

Authors:  Romain Itier; Maeva Guillaume; Jean-Etienne Ricci; François Roubille; Nicolas Delarche; François Picard; Michel Galinier; Jérôme Roncalli
Journal:  ESC Heart Fail       Date:  2021-02-03

6.  Non-invasive markers of liver fibrosis and outcome in large vessel occlusion stroke.

Authors:  Simon Fandler-Höfler; Rudolf E Stauber; Markus Kneihsl; Gerit Wünsch; Melanie Haidegger; Birgit Poltrum; Alexander Pichler; Hannes Deutschmann; Christian Enzinger; Peter Fickert; Thomas Gattringer
Journal:  Ther Adv Neurol Disord       Date:  2021-08-31       Impact factor: 6.570

Review 7.  Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes.

Authors:  Alessandro Mantovani; Andrea Dalbeni; Giorgia Beatrice; Davide Cappelli; Fernando Gomez-Peralta
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

Review 8.  NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.

Authors:  Valerio Rosato; Mario Masarone; Marcello Dallio; Alessandro Federico; Andrea Aglitti; Marcello Persico
Journal:  Int J Environ Res Public Health       Date:  2019-09-14       Impact factor: 3.390

9.  The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index.

Authors:  Hyo Eun Park; Heesun Lee; Su-Yeon Choi; Hua Sun Kim; Goh Eun Chung
Journal:  Sci Rep       Date:  2020-03-19       Impact factor: 4.379

Review 10.  Epicardial Adipose Tissue: Clinical Biomarker of Cardio-Metabolic Risk.

Authors:  Alexandra C Villasante Fricke; Gianluca Iacobellis
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.